Paid Clinical Trials Rochester

Discover 468 paid clinical trials in Rochester. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 468

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Recruiting

PHASE1

PHASE2

Sponsor:

Vaccinex Inc.

Location:

Rochester, Pittsburgh, Canton, Lake Successshow 14 more

Code:

NCT04815720

Conditions

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

pepinemab + pembrolizumab

Ribociclib and Bicalutamide in AR+ TNBC

Recruiting

PHASE1

PHASE2

Sponsor:

Kari Wisinski

Location:

Rochester, Hershey, New Brunswick, Lansingshow 2 more

Code:

NCT03090165

Conditions

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ribociclib

Bicalutamide

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting

PHASE2

PHASE3

Sponsor:

Biogen

Location:

Fairport, Ottawa, Hershey, Clevelandshow 50 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Rochester, Syracuse, London, Pittsburghshow 21 more

Code:

NCT04779320

Conditions

Crohn's Disease (CD)

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Vedolizumab IV

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Rochester, Buffalo, Syracuse, Erieshow 351 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Prospective Study of Pregnancy in Women With Cystic Fibrosis

Recruiting

Sponsor:

Amalia Magaret

Location:

Rochester, Buffalo, Syracuse, Pittsburghshow 35 more

Code:

NCT04828382

Conditions

Pregnancy Related

Cystic Fibrosis

Eligibility Criteria

Sex: Female

Age: 16+

Healthy Volunteers: Not accepted

Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research

Recruiting

Sponsor:

Huntington Study Group

Location:

Rochester

Code:

NCT06343220

Conditions

Huntington Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

The PEERLESS II Study

Recruiting

Sponsor:

Inari Medical

Location:

Rochester, Buffalo, Erie, Harrisburgshow 47 more

Code:

NCT06055920

Conditions

Pulmonary Embolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FlowTriever System

Anticoagulation Agents

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Rochester, Scottdale, Stamford, Smithfieldshow 74 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%

Recruiting

PHASE3

Sponsor:

Grifols Therapeutics LLC

Location:

Rochester, Pittsburgh, Newark, Philadelphiashow 11 more

Code:

NCT03702920

Conditions

Acute-On-Chronic Liver Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

SMT + PE-A 5%

Standard Medical Treatment